HuagongsheHuagongshe Chemistry Print Report · For research reference only
Ethyl (morpholin-4-ylcarbonothioyl)carbamate → {[1-(4-Cyano-1-propyl-piperidin-4-ylcarbamoyl)-2-cyclohexyl-ethylimino]-morpholin-4-yl-methyl}-carbamic acid ethyl ester
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Ethyl (morpholin-4-ylcarbonothioyl)carbamate | HCID 2824559 | — |
| Reactant | 2-amino-N-(-4-cyano-1-propyl-piperidin-4-yl)-3-cyclohexylpropionamide bis hydrochloride salt | HCID 86585200 | — |
| Product | {[1-(4-Cyano-1-propyl-piperidin-4-ylcarbamoyl)-2-cyclohexyl-ethylimino]-morpholin-4-yl-methyl}-carbamic acid ethyl ester | HCID 22091416 | — |
Reaction Steps
The title compound was prepared starting from (Morpholine-4-carbothioyl)-carbamic acid ethyl ester and 2-amino -N-(-4-cyano-1-propyl-piperidin-4-yl)-3-cyclohexylpropionamide bis hydrochloride salt according to the procedure from Example 76, step b, except that the compound was first purified by chromatography over silica gel using 9:1 methylene chloride: methanol as the eluant prior to reverse phase HPLC purification. MS, m/z 505=M+1.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US06756372B2 |
| Source dataset | uspto-grants-2004_06 |
| ORD ID | ord-96ccf8539dfc499bb9261af036788a68 |
| Source note | uspto-grants-2004_06 |